Skip to main content

Table 1 Demographic and treatment-related characteristics of patients in those with and without GI symptoms

From: Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study

N (%)

GI symptoms (n = 21)

No GI symptoms (n = 34)

Male

20 (95)

29 (85)

Hospitalized patients

5 (24)

9 (27)

Median (IQR)

  

Age

28 (14)

35 (21)

Hospital attendances

1 (2)

1 (3)

Duration of hospitalization*

3 (4)

8 (7)

  1. GI: gastro-intestinal
  2. *In hospitalized patients